Correction of a reference to Clinical Laboratory Standards Institute Interpretive Criteria

被引：4

作者：

Wikler, Matthew A. ^{[1
,3
]}

Ferraro, Mary Jane ^{[2
,4
,5
]}

机构：

[1] Antimicrobial Susceptibil Testing Subcomm, Wayne, PA USA

[2] Clin & Lab Stand Inst, Area Comm Microbiol, Wayne, PA USA

[3] Pacific Beach Biosci, San Diego, CA 92121 USA

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Harvard Univ, Sch Med, Boston, MA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2008年 / 46卷 / 11期

关键词：

D O I：

10.1086/588056

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1798 / 1798

页数：1

共 50 条

[1] The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus
Tenover, Fred C.
Moellering, Robert C., Jr.
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (09) : 1208 - 1215
[2] Determination of Tedizolid susceptibility interpretive criteria for gram-positive pathogens according to clinical and laboratory standards institute guidelines
Bensaci, Mekki
Flanagan, Shawn
Sandison, Taylor
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 90 (03) : 214 - 220
[3] Evaluation of Clinical Laboratory Standards Institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs
Schissler, Jennifer R.
Hillier, Andrew
Daniels, Joshua B.
Cole, Lynette K.
Gebreyes, Wondwossen A.
[J]. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2009, 21 (05) : 684 - 688
[4] Proposed changes to Clinical Laboratory Standards Institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs
Papich, Mark G.
[J]. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2010, 22 (01) : 160 - 160
[5] Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam
Dudley, Michael N.
Ambrose, Paul G.
Bhavnani, Sujata M.
Craig, William A.
Ferraro, Mary Jane
Jones, Ronald N.
[J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1301 - 1309
[6] Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae
Bartsch, Sarah M.
Huang, Susan S.
Wong, Kim F.
Slayton, Rachel B.
McKinnell, James A.
Sahm, Daniel F.
Kazmierczak, Krystyna
Mueller, Leslie E.
Jernigan, John A.
Lee, Bruce Y.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (11) : 2757 - 2762
[7] Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria
Kristo, Ioulia
Pitiriga, Vassiliki
Poulou, Aggeliki
Zarkotou, Olympia
Kimouli, Maria
Pournaras, Spyros
Tsakris, Athanassios
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (04) : 383 - 387
[8] Disk diffusion interpretive criteria for fusidic acid susceptibility testing of Staphylococci by the National Committee for Clinical Laboratory Standards method
Coutant, C
Olden, D
Bell, J
Turnidge, JD
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (01) : 9 - 13
[9] SUGGESTED DEFINITIONS FOR CLINICAL LABORATORY STANDARDS AND REFERENCE MATERIALS
HANSON, DJ
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1970, 54 (03) : 451 - &
[10] MOLECULAR CHARACTERIZATION OF EXTENDED-SPECTRUM BETA-LACTAMASES AND ITS CORRELATION WITH CLINICAL LABORATORY STANDARDS INSTITUTE INTERPRETIVE CRITERIA FOR DISK DIFFUSION SUSCEPTIBILITY TESTING IN ENTEROBACTERIACEAE ISOLATES IN THAIALND
Tangkoskul, Teerawit
Tiengrim, Surapee
Onsomang, Supiluck
Pati, Naratchaphan
Aswapokee, Nalinee
Thamlikitkul, Visanu
Chayakulkeeree, Methee
[J]. SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 43 (06) : 1461 - 1469

← 1 2 3 4 5 →